NovoCure Ltd Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q2 2017 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
NovoCure Ltd quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q2 2017 to Q3 2024.
- NovoCure Ltd Net Cash Provided by (Used in) Operating Activities for the quarter ending September 30, 2024 was $10.4M.
- NovoCure Ltd Net Cash Provided by (Used in) Operating Activities for the twelve months ending September 30, 2024 was -$37.5M, a 40% increase year-over-year.
- NovoCure Ltd annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$73.3M, a 338% decline from 2022.
- NovoCure Ltd annual Net Cash Provided by (Used in) Operating Activities for 2022 was $30.8M, a 62.8% decline from 2021.
- NovoCure Ltd annual Net Cash Provided by (Used in) Operating Activities for 2021 was $82.8M, a 16.5% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Trailing 12 Months (USD)
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)